SCHEMBL10212533

SCHEMBL10212533

Cc1nc(N)nc2c(C(C)C)cn(C)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19366629 0.83 — —
SCHEMBL12393894 0.83 HRH4 (0.33) —
SCHEMBL10212549 0.70 MAPKAPK2 (0.44) —
SCHEMBL17175014 0.64 PNP (0.32) —
SCHEMBL26866007 0.63 — —
SCHEMBL26865991 0.63 — —
SCHEMBL2611029 0.62 P2RX3 (0.45) —
SCHEMBL26866018 0.61 — —
SCHEMBL18165658 0.61 — —
SCHEMBL9286483 0.60 KDM4E (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 — — US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 — — US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 — — US disclosed
Send feedback